Skip to main content
SpringerLink
Log in

Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tse E, Gill H, Loong F, Kim SJ, Ng SB, Tang T, Ko YH, Chng WJ, Lim ST, Kim WS, Kwong YL (2012) Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol 87(7):663–668. https://doi.org/10.1002/ajh.23213

    Article  PubMed  Google Scholar 

  2. Kubota Y, Kusaba K (2018) Monomorphic epitheliotropic intestinal T-cell lymphoma involving the central nervous system. Blood 131(15):1765. https://doi.org/10.1182/blood-2017-11-819136

    Article  CAS  PubMed  Google Scholar 

  3. Chan TSY, Lee E, Khong PL, Tse EWC, Kwong YL (2018) Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma. Hematology 23(1):10–16. https://doi.org/10.1080/10245332.2017.1335979

    Article  PubMed  Google Scholar 

  4. Yi JH, Lee GW, Do YR, Jung HR, Hong JY, Yoon DH, Suh C, Choi YS, Yi SY, Sohn BS, Kim BS, Oh SY, Park J, Jo JC, Lee SS, Oh YH, Kim SJ, Kim WS (2019) Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma. Ann Hematol 98(11):2541–2550. https://doi.org/10.1007/s00277-019-03791-y

    Article  PubMed  Google Scholar 

  5. Shenkier TN, Blay JY, O'Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O'Brien P, Rubenstein J, Connors JM (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23(10):2233–2239. https://doi.org/10.1200/JCO.2005.07.109

    Article  PubMed  Google Scholar 

  6. Reni M, Zaja F, Mason W, Perry J, Mazza E, Spina M, Bordonaro R, Ilariucci F, Faedi M, Corazzelli G, Manno P, Franceschi E, Pace A, Candela M, Abbadessa A, Stelitano C, Latte G, Ferreri AJ (2007) Temozolomide as salvage treatment in primary brain lymphomas. Br J Cancer 96(6):864–867. https://doi.org/10.1038/sj.bjc.6603660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Baron M, Belin L, Cassoux N, Fardeau C, Blaizeau M, Soussain C, Houillier C, Hoang-Xuan K, Gyan E, Le Lez ML, Lavaud A, Soubeyran P, Bodaghi B, Costopoulos M, Leblond V, Touitou V, Maloum K, Errera MH, Roos-Weil D, Le Garff-Tavernier M, Choquet S (2020) Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma. Blood 135(20):1811–1815. https://doi.org/10.1182/blood.2019003073

    Article  PubMed  Google Scholar 

  8. Bird TG, Whittaker S, Wain EM, Child F, Morris SL (2016) Temozolomide for central nervous system involvement in mycosis fungoides. Int J Dermatol 55(7):751–756. https://doi.org/10.1111/ijd.13007

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong, SAR

    Pui-Lun Yip, Ching-Pong Lam, Wai-Pan Lau, Tsan-Hei Luk & Sze-Man June Lau

Authors
  1. Pui-Lun Yip
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ching-Pong Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wai-Pan Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tsan-Hei Luk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sze-Man June Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PLY treated the patient and wrote the manuscript. All authors treated the patient and approved the manuscript.

Corresponding author

Correspondence to Pui-Lun Yip.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Patient’s family provided informed consent for publishing.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yip, PL., Lam, CP., Lau, WP. et al. Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma. Ann Hematol 100, 3049–3050 (2021). https://doi.org/10.1007/s00277-020-04282-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04282-1

Search

Navigation